Noradrenalin Hameln (Noradrenaline Tartrate)

Noradrenaline Tartrate, the active ingredient in Noradrenalin Hameln, is a sympathomimetic amine presented as an injection solution for intravenous use. It is employed to raise blood pressure in acute hypotensive states such as septic shock and cardiac arrest.

GNH USA supplies Noradrenalin Hameln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Noradrenalin Hameln is a vasopressor used in critical care to support circulatory function.

- Hypotension: restores arterial pressure and improves organ perfusion in patients with acute low blood pressure. - Septic shock: counteracts vasodilatory shock by inducing vasoconstriction and enhancing cardiac output. - Cardiac arrest: provides immediate circulatory support during resuscitation efforts.

Noradrenalin Hameln may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: transient headache reported during infusion. - Tachycardia: increased heart rate due to beta‑1 stimulation. - Palpitations: sensation of rapid or irregular heartbeat. - Nausea: mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Peripheral ischemia: reduced blood flow leading to tissue necrosis. - Hypertensive crisis: excessive rise in blood pressure. - Extravasation injury: tissue damage if the drug leaks from the vein.

When using Noradrenalin Hameln, clinicians should observe several safety measures to minimize risks. - Cardiovascular monitoring: continuously monitor blood pressure and heart rate during infusion. - Dose titration: adjust infusion rate to achieve target hemodynamic goals. - Contraindications: avoid use in patients with uncorrected pheochromocytoma or severe peripheral vascular disease. - Drug compatibility: do not mix with solutions containing calcium or bicarbonate. - Patient assessment: evaluate for signs of ischemia, arrhythmia, or excessive hypertension. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenalin Hameln can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Beta‑blockers: may blunt the desired increase in heart rate and blood pressure. - MAO inhibitors: can potentiate hypertensive response. - Tricyclic antidepressants: increase risk of severe hypertension.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may cause additive cardiovascular effects. - Diuretics: can exacerbate hypovolemia, requiring careful volume management. - Inhaled anesthetics: may alter vascular response to noradrenaline.